KAYLA SPEARS: Open Payments
NPI 1114693108 · MICHIGAN CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,750 in 93 payments from 26 companies in 2025. Trend: 2023 $2,314 · 2024 $2,009 · 2025 $1,750
Food & beverage: $1,750
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $195 |
| Amgen Inc. | 9 | $165 |
| AstraZeneca Pharmaceuticals LP | 9 | $160 |
| Novo Nordisk Inc | 7 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $136 |
| Vanda Pharmaceuticals Inc. | 3 | $109 |
| PFIZER INC. | 6 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| Lilly USA, LLC | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
Products named: VRAYLAR, OTEZLA, Kerendia, JARDIANCE, FANAPT, Wegovy, AIRSUPRA, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
